IDNA: iShares Genomics Immunology and Healthcare ETF
Performance
Watchlist
Select an item
Summary
IDNA at a glance
IDNA returned +47.62% over the past year and -3.32% a year over five years. Its worst drop in that year was -12.98%, smaller than 43% of ETFs on Redstone, and its Sharpe ratio of 1.29 beats 94% of ETFs on Redstone. It yields 0.73%.
Current Drawdown
-12.98%
Rolling Volatility
40.26%
Dividends
IDNA dividends
Yield
0.73%
Paid, past year
$0.28
Pays
Twice a year
Growth a year
+60.3%
Per share, by year
Yearly return over 5 years
IDNA paid $0.28 a share over the past year, twice a year. Its yearly rate rose from $0.12 in 2023 to $0.31 in 2025, 60.3% a year. With dividends reinvested it returned -3.32% a year over five years, against -4.23% on price alone.
›All 9 payments since Dec 13, 2021
- Jun 15, 2026$0.1254
- Dec 16, 2025$0.1555
- Jun 16, 2025$0.1529
- Dec 17, 2024$0.1111
- Jun 11, 2024$0.1114
- Dec 20, 2023$0.1692
- Jun 7, 2023$0.0708
- Jun 9, 2022$0.1359
- Dec 13, 2021$0.2564
Metrics
Risk Indicators
Profile
About IDNA
The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering.
From its prospectus, filed Nov 28, 2025- Category
- Health Care
- Expense ratio
- 0.47%
- Fund size
- $321M
- Inception
- Jun 2019
Rankings
Lists IDNA is on
Comparisons